The pharmaceutical landscape for diabetes is shifting, and these patches represent a exciting advance. Unlike shots, this method offers a simpler way to deliver GLP-1 drugs. These devices steadily release the medication through the epidermis offering a even dose of the beneficial agent, which can enhance blood sugar regulation and potentially lower